TherapeuticsMD, Inc.

Historical 13F Holders

Symbol
TXMD
CUSIP
88338N206
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 88338N206 since 12/18/2024, largest first.

Filer % of Class Filed
Baselake Partners, LP 13G/A
6.8% 8/5/2026
Event 6/30/2026
Clearline Capital LP 13G
5.5% 2/12/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 13 164 k $332k
2026 Q2 47 3.67 M $9.10M
2026 Q1 50 3.93 M $7.94M
2025 Q4 45 3.39 M $5.52M
2025 Q3 46 3.30 M $3.54M
2025 Q2 45 3.26 M $3.78M
2025 Q1 44 3.34 M $3.09M
2024 Q4 42 3.53 M $3.03M
2024 Q3 39 3.38 M $5.61M
2024 Q2 39 3.54 M $5.70M
2024 Q1 44 3.64 M $8.34M
2023 Q4 42 3.38 M $7.61M
2023 Q3 39 2.99 M $9.32M
2023 Q2 44 3.03 M $12.5M
2023 Q1 44 3.12 M $11.7M
2022 Q4 47 3.50 M $19.6M
2022 Q3 45 2.07 M $13.8M
2022 Q2 56 2.07 M $20.2M
2022 Q1 2 10.8 k $4.10k
2021 Q4 1 10.0 k $3.56k